|
|
|
Insider
Information: |
Davie Joseph Md Phd |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
28,065 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,676 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
28,065 |
|
|
Total
Value |
$6,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Armata Pharmaceuticals, Inc |
ARMP |
Director |
2008-05-15 |
21,000 |
2007-05-17 |
0 |
Premium* |
|
CV Therapeutics Inc |
CVTX |
Director |
2009-04-02 |
7,065 |
2009-04-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
4 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARMP |
Armata Pharmaceuticals, I... |
Director |
|
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
11,000 |
0 |
- |
|
ARMP |
Armata Pharmaceuticals, I... |
Director |
|
2008-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
21,000 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Director |
|
2009-04-02 |
4 |
OE |
$8.74 |
$304,625 |
D/D |
27,500 |
15,462 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
Director |
|
2009-04-02 |
4 |
D |
$19.92 |
$407,065 |
D/D |
(20,435) |
7,065 |
0 |
- |
|
4 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|